Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AVENUE THERAPEUTICS, INC. | atxi-20210630xex32d2.htm |
| EX-31.2 - EXHIBIT 31.2 - AVENUE THERAPEUTICS, INC. | atxi-20210630xex31d2.htm |
| EX-31.1 - EXHIBIT 31.1 - AVENUE THERAPEUTICS, INC. | atxi-20210630xex31d1.htm |
| 10-Q - FORM 10-Q - AVENUE THERAPEUTICS, INC. | atxi-20210630x10q.htm |
Exhibit 32.1
Certification of
Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Lucy Lu, M.D., Chief Executive Officer of Avenue Therapeutics, Inc. (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021 (the “Report”) filed with the Securities and Exchange Commission:
●Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
●The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ Lucy Lu, M.D. |
| Lucy Lu, M.D. |
| President, Chief Executive Officer and Director |
| (Principal Executive Officer) |
| August 16, 2021 |